OBAGI-C RX System NORMAL-DRY SKIN INTERVENTION is a Kit in the Human Prescription Drug category. It is labeled and distributed by Obagi Cosmeceuticals Llc. The primary component is .
| Product ID | 62032-535_9cd0dc6c-2478-4b07-892c-895098e5c81a | 
| NDC | 62032-535 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | OBAGI-C RX System NORMAL-DRY SKIN INTERVENTION | 
| Generic Name | Hydroquinone, Homosalate, Octisalate, And Zinc Oxide | 
| Dosage Form | Kit | 
| Marketing Start Date | 2019-12-02 | 
| Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER | 
| Labeler Name | Obagi Cosmeceuticals LLC | 
| Active Ingredient Strength | 0 | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2022-12-31 | 
| Marketing Start Date | 2019-12-02 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 62032-518 | OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION | OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION | 
| 62032-524 | OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION | OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION | 
| 62032-532 | NU-DERM system NORMAL-DRY | Hydroquinone, Homosalate, Octisalate, and Zinc Oxide | 
| 62032-531 | NU-DERM System NORMAL-Oily | HYDROQUINONE, HOMOSALATE, OCTISALATE, and ZINC OXIDE | 
| 62032-533 | NU-DERM system NORMAL-oily | Hydroquinone, Homosalate, Octisalate, and Zinc Oxide | 
| 62032-535 | OBAGI-C RX System NORMAL-DRY | HYDROQUINONE, HOMOSALATE, OCTISALATE, AND ZINC OXIDE |